The innovative Doctor of Pharmacy curriculum prepares students for a broad array of careers in pharmacy. Students are admitted to the Pharm.D. program after completing a minimum of 63 semester hours (e.g., 2 years) of preprofessional collegiate study at an accredited college or university. Subsequent to admission, pharmacy students must satisfactorily complete four (4) years of professional study. Pharmacy core courses include the basic pharmaceutical sciences (i.e., immunology/biotechnology, medicinal chemistry, pharmacology, pharmaceutics, biopharmaceutics), followed by courses in clinical pharmacy practice (i.e., pathophysiology/therapeutics, drug information/literature evaluation, and pharmacokinetics), pharmacy administration (i.e., pharmaceutical economics, health care delivery) and pharmacy law. Introductory Practice Experiences which are integrated with the didactic course work are completed over the first three professional years of the curriculum. We offer students the opportunity to differentiate their degree by participating in a series of elective tracks during the third professional year. These tracks include a chance to earn a certificate in Business through a collaborative agreement between the School of Pharmacy and the University’s Fox School of Business and Management. Students also have the ability to complete specialty elective tracks in Advanced Clinical Practice, Clinical Research, Drug Safety and Nuclear Pharmacy during the third professional. The fourth year is comprised of 36 weeks of Advanced Pharmacy Practice Experiences completed under the supervision of a faculty preceptor. In addition to the Doctor of Pharmacy (Pharm.D.), we offer the Master of Science (M.S.) and Doctor of Philosophy (Ph.D.) degrees in Pharmaceutics, Pharmacodynamics and Medicinal Chemistry. Our Master of Science program in Quality Assurance/Regulatory (QA/RA) is the most comprehensive in the world.

Key Faculty

Michael Borenstein, Ph.D.
Associate Dean
michael.borenstein@temple.edu

Marquette Cannon-Babb, Pharm.D.,  GCDL
Assistant Dean for Admissions
marquette.cannon-babb@temple.edu

Research and Labs

• The Current Good Manufacturing Practices Lab
• The Jayne Haines Center for Pharmacogenomics and Drug Safety
• The Moulder Center for Drug Discovery Research

Tuition and other Financial Information:

Doctor of Pharmacy
Full-time
In-State: $30,670.00
Out-of-State: $35,134.00

www.temple.edu/bursar/about/tuitionrates.htm

Recognition and Awards

Accreditation Statement
Accreditation Council for Pharmacy Education certifies that Temple University School of Pharmacy has fulfilled the accreditation requirements set forth by ACPE for the Professional Degree Program in Pharmacy and is hereby granted: Accreditation Status through
June 30, 2017.

AWARDS

Magid Abou-Gharbia, Laura H. Carnell Professor of Medicinal Chemistry, was one of five former Wyeth (now Pfizer) scientists to be honored with the American Chemical Society’s 2014 Heroes of Chemistry award. He and his colleagues were recognized for their discovery of the antidepressant Effexor, regarded as a breakthrough therapy for depression, which has benefited over 25 million patients worldwide. Abou-Gharbia, who is also associate dean for research and director of the Moulder Center for Drug Discovery Research in the School of Pharmacy, was formerly senior vice president and head of chemical and screening sciences at Wyeth.

The Moulder Center for Drug Discovery Researchhas been awarded a 5 year NIH R01 grant to support the identification of novel therapies for the treatment of cocaine addiction and withdrawal.  The program will focus on developing compounds capable of increasing the expression of Glutamate Transporter 1 (GLT-1), an important component of glutamate re-uptake in the central nervous system.  Colleagues at John Hopkins University and the University of Florida will be collaborating with Moulder Center scientists on this $1.98 million project over the next 5 years.

Martinsried/Munich, Germany, and Philadelphia, USA, April 29, 2014: MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and The Moulder Center for Drug Discovery Research, a unit of Temple University’s School of Pharmacy, Philadelphia, Pa., USA, today announced a strategic alliance focused on the discovery of new therapeutic antibodies. Under the terms of the agreement, the Moulder Center will receive access to MorphoSys’s Ylanthia® technology for use in validating new disease-related targets and generating therapeutic antibody candidates.

PHILADELPHIA--(BUSINESS WIRE)--Four promising technologies are one step closer to the marketplace thanks to funding from the University City Science Center’s QED Proof-of-Concept Program. Life science and health IT researchers from Drexel University, Temple University and Rutgers, The State University of New Jersey, received a total of $600,000 through the QED program to develop a potential drug therapy for Lou Gehrig’s disease; validate a new therapeutic compound for pancreatic cancer; develop software to analyze EEG readings and guide diagnosis; and improve communications skills of health care professionals.

The Golden Apple Awardis sponsored by the Dean’s office in recognition of teaching excellence and innovation by faculty at Temple University School of Pharmacy.  This year’s winners are: Pharmacy Practice Department, the award will be shared by Dr. Nicole Sifontis and Dr. Carol Holtzman for their development of a new elective in public health that has been lauded by students for its innovative quality. Pharmaceutical Sciences Department, the award is given to Dr. Swati Nagar for her sustained excellence in the classroom.

University/School History

Temple University School of Pharmacy (TUSP) was established in 1901 to provide students access to professional education in the discipline of pharmacy. Reasons for considering TUSP as an institution of your choice includes:
LOCATION — 6th largest comprehensive Health Sciences campus in America & epicenter of the pharmaceutical industry.
DIVERSITY — enrollment of a diverse student population from all parts of America and the world.

OPPORTUNITIES FOR PROFESSIONAL LEARNING
Among the top 100 USA research intensive institutions
The Moulder Center for Drug Discovery Research
The Jayne Haines Center for Pharmaco-Genomics and Drug Safety
Has one of only 6 cGMP manufacturing facilities in the country.
Nuclear Magnetic Resonance (NMR) Facility

Comprehensive Pharmacy Practice Experiences
IPPEs & APPEs
Over 350 experiential sites
Clinical research opportunities
Development of professional portfolios via published articles and national presentations

Other Information

TUSP 2013 graduates achieved a 99.2% pass rate on the NAPLEX, or North American Pharmacist Licensure Examination.

TUSP provides a comprehensive learning environment including a patient simulation teaching and parenterals laboratory, respectively.

TUSP promotes professional and career development initiatives.